NCT01951001View on ClinicalTrials.gov

Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome

PHASE4CompletedINTERVENTIONAL

Enrollment

255

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

October 31, 2018

Conditions

Acute Coronary SyndromePlatelet ThrombusBleeding

Interventions

DRUG

Prasugrel

For fixed-dose group, patients will receive prasugrel 10 or 5 mg/d for 1 month Irrespective of platelet function test.

Trial Locations (1)

660-702

Gyeonsang National University Hospital, Jinju

All Listed Sponsors

lead

Gyeongsang National University Hospital

OTHER

NCT01951001 - Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter